Issue : Clinical Pharmacist, 2013

Dyslipidaemia management Subscription

Lifestyle changes, such as smoking cessation, losing weight and increasing physical activity, can reduce cardiovascular risk for patients with dyslipidaema. Statins are used first line for most patients. Beyond statins, the National Institute for Health and Care Excellence suggests that ezetimibe in combination with statin therapy can be considered, but should be reserved until statin therapy has been fully optimised. 

What leaders can do to help others cope with change Subscription

Last year I was one of three pharmacists selected to undertake the inaugural NHS clinical leadership fellowship programme. If you had asked me what I thought leadership meant before the programme, I would have said that I regarded a leader as being the captain of a ship: someone who has a vision and a crew to implement that vision. Indeed, this ...

Is strontium ranelate safe to use for patients with renal impairment? Subscription

UK Medicines Information

How to improve health outcomes for patients with learning disabilities Subscription

People with learning disabilities find it difficult to understand new or complex information, learn new skills or cope independently. They often have poorer health outcomes compared with the general population and are at risk of dying from causes that are preventable.

Qualified Persons: what they do and how you can become one Subscription

Have you heard of the Qualified Person and wondered exactly what they are qualified to do? Read on to find out why the QP role is essential in pharmaceutical manufacturing and how you can become eligible

Antioxidants and chemotherapy: can they be used in combination? Subscription

UK Medicines Information

Idiopathic pulmonary fibrosis: Clinical features and diagnosis Subscription

diopathic pulmonary fibrosis (IPF) is one of a large group of conditions, collectively referred to as interstitial lung diseases, that are similar in clinical and radiological presentation. Although the cause of IPF is unknown, several risk factors — such as environmental exposure to harmful substances and viral infection — have been suggested 

Idiopathic pulmonary fibrosis management Subscription

What to consider when prescribing for lactose-intolerant adults Subscription

UK Medicines Information summarises the evidence for this frequently asked question:

Plan the perfect presentation to conquer your presenting nerves Subscription

Conference participants get the most out of presentations that are easy to follow and relevant to their needs. Learn how to prepare a presentation that conveys your message and pleases your audience, too